Clarifying Baseline Cognitive Eligibility and Cross-Scale Follow-Up in a Randomized Trial of Remimazolam Tosylate for Laparoscopic Surgery [Response To Letter]
Jingya Liu, Mengyu Li, Huimin Wang, Sheng Wang · 2026
Read Clarifying Baseline Cognitive Eligibility and Cross-Scale Follow-Up in a Randomized Trial of Remimazolam Tosylate for Laparoscopic Surgery [Response To Letter] by Jingya Liu, Mengyu Li, Huimin Wang, Sheng Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13209140.txt.
Description
Jingya Liu and co-authors answer a letter questioning the scoring rules of their trial of remimazolam, a sedative used in keyhole surgery. A reader had noted that some patients' raw thinking-test scores fell below the trial's entry cutoff. In this 2026 response, the authors explain that screening used scores adjusted for years of schooling, adding points for patients with less education, so every enrolled patient passed once adjusted. They argue the common one-point fix undercorrects for schooling bias, and they lay out their tiered adjustment scheme in full.
Catalog record
| CREATOR | Jingya Liu, Mengyu Li, Huimin Wang, Sheng Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |